News & Events
of the Peripheral Nerve Society2026 PNS Junior Member Abstract Prize Winners Announced

Each year the PNS gives named prizes for the best abstracts to young investigators. In evaluating each presentation, the prize committee considers the quality of the presentation, groundbreaking and/or innovative results, and the quality of the presenter. The prizes are named for luminaries in our field, whose major scientific achievements in peripheral neuropathies would inspire the next generation of scientists.
Congratulations to those that received awards this year:
Peter J. Dyck Prize for Research in Diabetic Neuropathies
Maiken Krogsbæk Bøgh
Beyond Fiber Loss: Spatial Transcriptomic Profiling of Painful Diabetic Neuropathy
J. W. Griffin Prize for Research in Regeneration
Max Stewart
Pre-Operative Electrical Stimulation to Improve Outcomes After Carpal Tunnel Decompression: a Randomised, Triple-Blind Placebo-Controlled Trial
Richard and Mary Bunge Prize for Outstanding Insights in Nerve Biology
Juan Sebastián Jara
Distinct DRG macrophage polarization states associate with divergent sensory neuron outcomes after nerve injury
Anita Harding Prize Given in Honor of a Female Pioneer and Awarded to a Female Presenting Author
Thu Pham
Gene Regulatory Networks of Paclitaxel-Induced Peripheral Neurotoxicity in Human Sensory Neurons
Arthur K. Asbury Prize for Research in the field of GBS/CIDP/Inflammatory Neuropathies
Anouk van Dommelen
Longitudinal Serum Neurofilament Light Chain In Patients With Guillain-Barré Syndrome
P. K. Thomas Prize for Contribution to the Field of Inherited Neuropathies
Maike Dohrn
FAM169A-linked Nuclear Envelopathy is a New Mendelian Disease of Motor Axons
Jonathan Pembroke Prize Awarded to a Young Researcher Working in Australia, South Asia, or New Zealand
Anke Claessens
HDAC6 deletion mitigates axonal pathology in a mouse model of Charcot-Marie-Tooth disease type 2J
Richard A.C. Hughes Prize for Oustanding Clinical Research
Eveline Wiegers
Comparative effectiveness of imlifidase versus intravenous immunoglobulin treatment for Guillain-Barré syndrome